Home
Crescita Therapeutics

Crescita Therapeutics Market Share Analysis for June 2026

Crescita Therapeutics is a commercial dermatology company with a portfolio of prescription and non-prescription products for the treatment and care of skin conditions, diseases and their symptoms.

Industry: N/A

Domaincrescitatherapeutics.com

Year Founded2016

Employees51 - 200

Annual Revenue$15M - $25M

Crescita Therapeutics

Crescita Therapeutics (including company regionals)

crescitatherapeutics.com

See more website traffic and engagement information

Crescita Therapeutics Revenue up to June 2026 is 15M - 25M

revenue generated by Crescita Therapeutics top domains

Crescita Therapeutics top domains revenue over 3 years

Revenue for Crescita Therapeutics top domains

crescitatherapeutics.com15M - 25M

See more with Sales Intelligence

Total visits to Crescita Therapeutics's top domains

Understand Crescita Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

crescitatherapeutics.com1.1K

See more with Sales Intelligence

Avg. visit duration in Crescita Therapeutics's top domains

Analyze Crescita Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

crescitatherapeutics.com00:00:30

See more with Sales Intelligence

Avg. pageviews on Crescita Therapeutics's top domains

See how Crescita Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

crescitatherapeutics.com1.62

See more with Sales Intelligence

Crescita Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Crescita Therapeutics

These are the website technologies, by industry, used by Crescita Therapeutics top domains

Advertising (5)

DoubleClick

Widget (5)

Twemoji

Conversion & Analytics (3)

Google Analytics

Audio Video Media (2)

YouTube

More Technologies

10

See all

News & Signals from Crescita Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCrescita Therapeutics Inc. acquires Assets for $900K.Pursuant to the terms of the Purchase Agreement, Crescita acquired the Assets for total cash consideration of $0.9 million.

NewsCrescita Therapeutics Inc. is developing formulations for topical cannabis and hemp products.Pursuant to the Agreement, Crescita will develop formulations for topical cannabis and hemp products using its patented transdermal delivery technologies: Multiplexed Molecular Penetration Enhancers ™ ("MMPE") and DuraPeel ™ ("DuraPeel").

NewsCrescita Therapeutics Inc. is developing enhanced version of Tetra.Crescita Therapeutics ( OTC:CRRTF ) and Tetra Natural Health, a subsidiary of Tetra Bio-Pharma ( OTCQB:TBPMF ) collaborates to develop an enhanced version of Tetra's dermatology portfolio using Crescita's patented transdermal delivery technologies: Multiplexed Molecular Penetration Enhancer ("MMPE") and DuraPeel.